0000950170-24-043769.txt : 20240411
0000950170-24-043769.hdr.sgml : 20240411
20240411170203
ACCESSION NUMBER: 0000950170-24-043769
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240410
FILED AS OF DATE: 20240411
DATE AS OF CHANGE: 20240411
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Savage William Jacob
CENTRAL INDEX KEY: 0001951852
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39438
FILM NUMBER: 24839180
MAIL ADDRESS:
STREET 1: C/O DISC MEDICINE, INC.
STREET 2: 321 ARSENAL STREET, SUITE 101
CITY: WATERTOWN
STATE: MA
ZIP: 02472
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Disc Medicine, Inc.
CENTRAL INDEX KEY: 0001816736
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 851613057
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 321 ARSENAL STREET, SUITE 101
CITY: WATERTOWN
STATE: MA
ZIP: 02472
BUSINESS PHONE: (617) 674-9274
MAIL ADDRESS:
STREET 1: 321 ARSENAL STREET, SUITE 101
CITY: WATERTOWN
STATE: MA
ZIP: 02472
FORMER COMPANY:
FORMER CONFORMED NAME: Gemini Therapeutics, Inc. /DE
DATE OF NAME CHANGE: 20210209
FORMER COMPANY:
FORMER CONFORMED NAME: FS Development Corp.
DATE OF NAME CHANGE: 20200702
4
1
ownership.xml
4
X0508
4
2024-04-10
0001816736
Disc Medicine, Inc.
IRON
0001951852
Savage William Jacob
C/O DISC MEDICINE, INC.
321 ARSENAL STREET, SUITE 101
WATERTOWN
MA
02472
false
true
false
false
Chief Medical Officer
false
Common Stock
2024-04-10
4
M
false
21870
2.65
A
43405
D
Stock Option (Right to Buy)
2.65
2024-04-10
4
M
false
13093
0.00
D
2030-08-10
Common Stock
13093
4233
D
Stock Option (Right to Buy)
2.65
2024-04-10
4
M
false
8777
0.00
D
2030-10-22
Common Stock
8777
1498
D
25% of the shares underlying this option vested on August 3, 2021, with the remaining shares vesting in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service on each such vesting date.
2,140 shares underlying this option vested on August 3, 2021, with the remaining shares vesting in 38 equal monthly installments thereafter, subject to the Reporting Person's continued service on each such vesting date.
By: /s/ Rahul Khara, as Attorney-in-Fact
2024-04-11